Results 81 to 90 of about 241,664 (350)

From omics to AI—mapping the pathogenic pathways in type 2 diabetes

open access: yesFEBS Letters, EarlyView.
Integrating multi‐omics data with AI‐based modelling (unsupervised and supervised machine learning) identify optimal patient clusters, informing AI‐driven accurate risk stratification. Digital twins simulate individual trajectories in real time, guiding precision medicine by matching patients to targeted therapies.
Siobhán O'Sullivan   +2 more
wiley   +1 more source

Valuation of Put Options on Leveraged Equity [PDF]

open access: yes
This paper presents new closed form solutions for the valuation of European put options and of "down-an-in" barrier options written on leveraged equity.
Marco Realdon
core  

The anabolic steroid stanozolol is a potent inhibitor of human MutT homolog 1

open access: yesFEBS Letters, EarlyView.
MutT homolog 1 (MTH1) is a member of the NUDIX superfamily of enzymes and is an anticancer drug target. We show that stanozolol (Stz), an anabolic steroid, is an unexpected nanomolar inhibitor of MTH1. The X‐ray crystal structure of the human MTH1–Stz complex reveals a unique binding scaffold that could be utilized for future inhibitor development ...
Emma Scaletti Hutchinson   +7 more
wiley   +1 more source

The Valuation of Real Options in a Hybrid Environment

open access: yesOperations Research and Decisions, 2019
The aim of this paper is to present the possibilities and purposefulness of the application of fuzzy set theory to the valuation of real options. Owing to temporal fluctuations in the market, some input parameters in a model of a real option cannot ...
Bogdan Rębiasz
doaj  

On Real Options and Information Costs. [PDF]

open access: yes
This paper presents a simple framework for the use of traditional capital budgeting models and the valuation of several real options in the presence of shadow costs of incomplete information. Information costs can be viewed as sunk costs in the spirit of
Bellalah, Mondher, El Farissi, Inass
core  

Aβ42 promotes the aggregation of α‐synuclein splice isoforms via heterogeneous nucleation

open access: yesFEBS Letters, EarlyView.
The aggregation of amyloid‐β (Aβ) and α‐synuclein (αSyn) is associated with Alzheimer's and Parkinson's diseases. This study reveals that Aβ aggregates serve as potent nucleation sites for the aggregation of αSyn and its splice isoforms, shedding light on the intricate interplay between these two pathogenic proteins.
Alexander Röntgen   +2 more
wiley   +1 more source

What do you do when the binomial cannot value real options? The LSM model

open access: yesCogent Economics & Finance, 2014
The Least-Squares Monte Carlo model (LSM model) has emerged as the derivative valuation technique with the greatest impact in current practice. As with other options valuation models, the LSM algorithm was initially posited in the field of financial ...
S. Alonso, V. Azofra, G. De La Fuente
doaj   +1 more source

Fuzzy real options valuation for oil investments

open access: yesTechnological and Economic Development of Economy, 2009
Traditional valuation methods are less viable under uncertainty. Hence, other methods such as real options valuation models, which can minimize uncertainty, have become more important.
İrem Uçal, Cengiz Kahraman
doaj   +1 more source

A semi-analytical approach to Canary swaptions in HJM one-factor model [PDF]

open access: yes
Leveraging the explicit formula for European swaptions and coupon-bond options in HJM one-factor model, we develop a semi-explicit formula for 2-Bermudan options (also called Canary options). We first extend the European swaption formula to future times.
Henrard Marc
core  

Real Options Valuation : an application to the portuguese real estate market [PDF]

open access: yes, 2008
The contribution of real options analysis on the valuation of Portuguese undeveloped building sites is significant on the decision making regarding the apartment-buildings construction. Using the options model developed by Quigg (1993), and including the
Couto, Gualter   +2 more
core  

Home - About - Disclaimer - Privacy